miRagen Therapeutics
MGEN
$23.01
Share price
-0.09%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for miRagen Therapeutics (MGEN)
Revenue in 2020 (TTM): $2.57 M
According to miRagen Therapeutics's latest financial reports the company's current revenue (TTM) is $2.57 M. In 2019 the company made a revenue of $4.46 M a decrease over the years 2018 revenue that were of $8.38 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for miRagen Therapeutics from 2013 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | $2.57 M | -42.37% |
| 2019 | $4.46 M | -46.8% |
| 2018 | $8.38 M | 109.49% |
| 2017 | $4 M | 19.96% |
| 2016 | $3.33 M | 31.43% |
| 2015 | $2.53 M | -44.42% |
| 2014 | $4.56 M | 2.39% |
| 2013 | $4.46 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | $58.44 M | 2,173.12% | 🇺🇸 USA |
 Oragenics OGEN | N/A | N/A | 🇺🇸 USA |
 OncoCyte
OCX | $1.5 M | -41.54% | 🇺🇸 USA |